Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

Home/The Filing Wire/Addex Therapeutics Ltd./ SCHEDULE 13D/A

SEC Filing · SCHEDULE 13D/A

Addex Therapeutics Ltd.

SEC Filing

Filed Sep 4, 2026Accepted Sep 4, 2026, 4:00 PM EDTCIK 1574232Accession 0001104659-26-105480
View company →Permanent SEC source ↗
Share

Company context

Current securities

ADXNNASDAQ · ADR · Current

Recent company filings

  1. 6-K filingSep 25, 2026
  2. 4 filingSep 4, 2026
  3. 4 filingSep 4, 2026
  4. 4 filingSep 4, 2026
  5. 4 filingSep 4, 2026

Document unavailable

This filing is not currently available in the archive. Read it on SEC EDGAR ↗